Professor of Medicine. Director, Inflammatory Bowel Disease Center
Gastroenterology
Dr. Dario R. Sorrentino, MD
|
|
Give Review
Dario R. Sorrentino, MD is an expert in the field of Gastroenterology. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Dario R. Sorrentino is a published doctor and has 85 publications published. The lastest was: 'Intestinal leiomyosarcoma and gastroparesis associated with von Recklinghausen's disease.' Doctor Dario R. Sorrentino, MD accepts Medicare.
Publications
- Long-term prevention of postoperative Crohn's Disease recurrence with azathioprine: the wolf in the sheep clothing.
- Tissue Studies in Screened First-degree Relatives Reveal a Distinct Crohn's Disease Phenotype.
- Stopping Anti-TNF Agents in Patients with Crohn's Disease in Remission: Is It a Feasible Long-term Strategy?
- Translational research and efficacy of biologics in Crohn's Disease: a cautionary tale.
- Infliximab versus Adalimumab for Crohn's Disease: Perhaps Too Early To Call It A Tie.
- Surgery for Crohn's Disease and anti-TNF agents: the changing scenario.
- Fibrocytes, Inflammation, and Fibrosis in Crohn's Disease: Another Piece of the Puzzle.
- State-of-the-art medical prevention of postoperative recurrence of Crohn's Disease.
- Mucosal healing and clinical remission in inflammatory bowel Diseases: are we missing something here?
- The role of magnetic resonance imaging in detecting Intestinal fibrosis in Crohn's disease.
- Ustekinumab induction and maintenance therapy in refractory Crohn's Disease.
- Bringing top-end endoscopy to regional australia: hurdles and benefits.
- The race for mainstream gastroIntestinal endoscopy: frontrunners.
- Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's Disease: partial benefit by infliximab--a pilot study.
- Recommendations for the treatment of Ulcerative colitis with infliximab: a gastroenterology expert group consensus.
- Acute severe colitis: infliximab and/or cyclosporine?
- Prevention of postoperative recurrence of Crohn's Disease: does the type of surgery matter?
- Diagnosis and assessment of Crohn's Disease: the present and the future.
- Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's Disease.
- Anti-TNF's for postoperative recurrence in Crohn's Disease: the if's and how's.
- [Prevention of post-surgical recurrence of Crohn's Disease. A perspective].
- Infliximab for postsurgical endoscopic recurrence of Crohn's Disease: no trumpets yet.
- Postoperative recurrence of Crohn's Disease: the beginning of the end?
- Internet use among inflammatory bowel Disease patients: an Italian multicenter survey.
- Infliximab in Crohn's Disease: a look at the (not so distant) future.
- Role of biologics and other therapies in stricturing Crohn's Disease: what have we learnt so far?
- MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's Disease of the terminal ileum.
- Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn Disease.
- "Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy.
- Fibrotic strictures and anti-TNF-alpha therapy in Crohn's Disease.
- Factors associated with the development of Intestinal strictures or obstructions in patients with Crohn's disease.
- Prevention of postoperative recurrence of Crohn's Disease by infliximab.
- Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's Disease.
- Heart-touching Chilaiditi's syndrome.
- Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale.
- Helicobacter pylori associated antigastric autoantibodies: role in Sjogren's syndrome Gastritis.
- Cavernous transformation of the portal vein associated to multiorgan developmental abnormalities.
- Organic anion-transporting polypeptides: expression cloning and functional tests.
- Scientific publications in gastroenterology and hepatology in Western Europe, USA and Japan in the years 1992-1996: a global survey.
- Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune Disease and i...
- Colorectal Cancer screening in Italy: feasibility and cost-effectiveness in a model area.
- Helicobacter pylori infection and autoimmune processes: an emerging field of study.
- Intestinal leiomyosarcoma and gastroparesis associated with von Recklinghausen's disease.
- Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune Diseases and with dyspepsia. A follow-up study.
- [Ethical aspects of randomized clinical trials].
- Hepatitis C virus infection and gastric lymphoproliferation in patients with Sjogren's syndrome.
- Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome.
- Hepatocellular sulfobromophthalein uptake at physiologic albumin concentrations: kinetic evidence for a high affinity/low capacity sinusoidal membrane system.
- Esophageal ulceration due to alendronate.
- B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma.
- Oleate uptake by isolated hepatocytes and the perfused rat liver is competitively inhibited by palmitate.
- Widespread clonal B-cell disorder in Sjogren's syndrome predisposing to Helicobacter pylori-related gastric lymphoma.
- Helicobacter pylori, gastric MALT and B-cell clonality.
- B cell clonality in gastric lymphoid tissues of patients with Sjogren's syndrome.
- Oleate uptake kinetics in the perfused rat liver are consistent with pseudofacilitation by albumin.
- The hepatocellular uptake of free fatty acids is selectively preserved during starvation.
- Unbound ligand drives hepatocyte taurocholate and BSP uptake at physiological albumin concentration.
- Characteristics of oleate binding to liver plasma membranes and its uptake by isolated hepatocytes.
- Sex differences in hepatic fatty acid uptake reflect a greater affinity of the transport system in females.
- Adipocyte differentiation of 3T3-L1 cells involves augmented expression of a 43-kDa plasma membrane fatty acid-binding protein.
- Hepatocellular 22Na+ uptake: effect of oleate.
- Functional and morphological features of isolated hepatocytes preserved in University of Wisconsin solution.
- Quantitation of plasma membrane fatty acid-binding protein by enzyme dilution and monoclonal antibody based immunoassay.
- Hepatocellular fatty acid uptake is mediated by a plasma membrane fatty acid binding protein closely related to mitochondrial glutamic oxaloacetic transaminase.
- Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related.
- From albumin to the cytoplasm: the hepatic uptake of organic anions.
- At physiologic albumin/oleate concentrations oleate uptake by isolated hepatocytes, cardiac myocytes, and adipocytes is a saturable function of the unbound oleate conc...
- Mechanisms of cellular uptake of free fatty acids.
- The hepatocellular transport of sulfobromophthalein-glutathione by clofibrate treated, perfused rat liver.
- Familial hyperbilirubinaemia syndromes: kinetic approaches.
- In vitro effects of epinephrine on Na influx into brush border vesicles from the rat kidney.
- 'Albumin-receptor' uptake kinetics do not require an intact lobular architecture and are not specific for albumin.
- Mechanistic aspects of hepatic bilirubin uptake.
- Oleate uptake by cardiac myocytes is carrier mediated and involves a 40-kD plasma membrane fatty acid binding protein similar to that in liver, adipose tissue, and gut.
- Continuous monitoring of the biliary excretion of a pulse of labelled compounds.
- Sex differences in sulfobromophthalein-glutathione transport by perfused rat liver.
- Bile acid secretion and pool size during phenobarbital induced hypercholeresis.
- Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut.
- Phenobarbital specifically increases the hepatocellular uptake of sulfobromophthalein-glutathione.
- Isolation and partial characterization of plasma membrane fatty acid binding proteins from myocardium and adipose tissue and their relationship to analogous proteins i...
- The hepatocellular uptake of bilirubin: current concepts and controversies.
- Hepatic disposition of clinically useful 5-nitrofurans.
- Nitrofurazone disposition by perfused rat liver. Effect of dose size and glutathione depletion.
- Transferrin metabolism in alcoholic liver Disease.
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Diaphragmatic and-or Hiatal Hernia
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Tier Hosp HealthKeepers DirectAccess VA
- HealthKeepers HMO
- KeyCare PPO
- Blue Card PPO
- Southern Health PPO
- Coventry Health Care of Virginia HMO
- Choice Care PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
Hospital
-
Carilion Roanoke Memorial Hospital
Drug Facts
| NPI NUMBER | 1952655417 | |
| NPPES Provider LastName | SORRENTINO | |
| NPPES Provider FirstName | DARIO | |
| NPPES Provider ZIPCode | 240164955 | |
| NPPES Provider State | VA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 49.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952655417 |
| Last Name Of The Provider | SORRENTINO |
| First Name Of The Provider | DARIO |
| View All |
Similar Doctors
|
Dr. Merritt J. Bern, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan A. Brijbassie, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin R. Dye, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan V. Burnstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sadat Rashid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marrieth G. Rubio, MD
This Doctor is OpenDoctor Recommended.
|